Evgenii Kovalev/E+ via Getty Images Investment Thesis The field of gene therapies and gene editing technology is the field of the future, but it is still in its infancy. CRISPR Therapeutics (NASDAQ:CRSP) has been a pioneer in this field, where scientists, for the first time ever, could be able to cure diseases and illnesses such as diabetes, hemophilia, cancer, and sickle cell disease. Diseases with genetic and systemic issues could possibly be cured with these advanced gene therapies. But, there have been ...